- Report
- April 2024
- 160 Pages
Global
From €4436EUR$4,969USD£3,863GBP
- Report
- April 2024
- 160 Pages
Global
From €4436EUR$4,969USD£3,863GBP
- Report
- April 2024
- 160 Pages
Global
From €4436EUR$4,969USD£3,863GBP
- Report
- April 2024
- 140 Pages
Global
From €4418EUR$4,949USD£3,847GBP
- Report
- February 2024
- 180 Pages
Global
From €4436EUR$4,969USD£3,863GBP
- Report
- February 2024
- 180 Pages
Global
From €4436EUR$4,969USD£3,863GBP
- Report
- February 2024
- 140 Pages
Global
From €4436EUR$4,969USD£3,863GBP
- Report
- February 2024
- 180 Pages
Global
From €4436EUR$4,969USD£3,863GBP
- Report
- February 2024
- 180 Pages
Global
From €4436EUR$4,969USD£3,863GBP
- Report
- February 2024
- 180 Pages
Global
From €4436EUR$4,969USD£3,863GBP
- Report
- February 2024
- 180 Pages
Global
From €4436EUR$4,969USD£3,863GBP
- Report
- February 2024
- 160 Pages
Global
From €4436EUR$4,969USD£3,863GBP
- Report
- December 2023
- 168 Pages
Global
From €4418EUR$4,949USD£3,847GBP
- Report
- November 2023
- 188 Pages
Mexico
From €3213EUR$3,599USD£2,798GBP
- Report
- November 2023
- 200 Pages
Global
From €3213EUR$3,599USD£2,798GBP
- Report
- November 2023
- 170 Pages
Global
From €3213EUR$3,599USD£2,798GBP
- Report
- November 2023
- 172 Pages
Global
From €3213EUR$3,599USD£2,798GBP
- Report
- October 2023
- 172 Pages
South Korea
From €3213EUR$3,599USD£2,798GBP
- Report
- September 2023
- 160 Pages
Global
From €3213EUR$3,599USD£2,798GBP
- Report
- September 2023
- 200 Pages
Global
From €3213EUR$3,599USD£2,798GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more